Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE817.8520.65 (+2.59 % )
PREV CLOSE (Rs.) 797.20
OPEN PRICE (Rs.) 800.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 100852
TODAY'S LOW / HIGH (Rs.)795.85 841.40
52 WK LOW / HIGH (Rs.)190.9 1025
NSE817.50 19.2 (+2.41 % )
PREV CLOSE(Rs.) 798.30
OPEN PRICE (Rs.) 804.00
BID PRICE (QTY) 817.50 (132 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1662329
TODAY'S LOW / HIGH(Rs.) 796.10 841.80
52 WK LOW / HIGH (Rs.)190.53 1026.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.06
TTM EPS (Rs.) 28.33
P/E Ratio 28.87
Book Value (Rs.) 89.54
Face Value (Rs.) 10
MCap (Rs. in Mn) 76223.62
Price/Earning (TTM) 24.43
Price/Sales (TTM) 4.08
Price/Book (MRQ) 9.13
PAT Margin (%) 8.30
ROCE (%) 21.29
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone :

Email : NA

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
20Apr04-20-2021$Aarti Drugs informs about letter to offer Aarti Drugs informs about le
Aarti Drugs has informed that Inga Ventures has submitted a copy of Letter of Offer to the Equity Shareholders/ Beneficial owners of Equity Shares of Aarti Drugs (Target Company).

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that Inga Ventures has submitted a cop..
19Mar03-19-2021$ Board approves Buy back of equity shares Board approves Buy back of
Aarti Drugs Ltd has informed BSE about Outcome of Board Meeting held on March 19, 2021.
Aarti Drugs Ltd has informed BSE about Outcome of Board Meeting..
16Mar03-16-2021$ Board Meeting Intimation for Buyback Of The Fully Paid-Up Equity Shares Of The Company Board Meeting Intimation fo
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/03/2021 ,inter alia, to consider and approve In compliance with Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, it is hereby informed that meeting of Board of Directors of the Company is scheduled to be held on Friday, March 19, 2021, to consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board..
16Mar03-16-2021$Aarti Drugs to consider share buyback proposal Aarti Drugs to consider shar

Aarti Drugs’ board is going to meet later this week to consider a share buyback proposal. A meeting of the Board of Directors of the company is scheduled to be held on Friday, March 19, 2021, to consider the proposal of buyback of the fully paid-up equity shares of the company.

Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs’ board is going to meet later this week to consid..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit646.61356.7
Gross Profit 851.5 1749.7
Operating Profit 1018.82454.6
Net Sales 472116349.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Hester Biosciences (BSE)
 2470.05 (11.53%)
M.Cap ( in Cr)
2101.24
Astrazeneca Pharma I (BSE)
 3840.05 (2.70%)
M.Cap ( in Cr)
9600.13
Themis Medicare (BSE)
 497.30 (6.82%)
M.Cap ( in Cr)
456.94
Caplin Point Lab (BSE)
 591.05 (4.82%)
M.Cap ( in Cr)
4470.86
Glaxosmithkline Phar (BSE)
 1503.80 (1.65%)
M.Cap ( in Cr)
25475.28
Shareholding Pattern More
PROMOTERS 60.2 %
NON-INSTITUTION 35.05 %
MUTUAL FUNDS/UTI 1.59 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes